The pitfalls of risk assessment in cryptocurrencies

Bitcoin addresses now in US sanctions lists

clock • 4 min read

Last month, the US Office of Foreign Assets Control (OFAC), employing the so-called Foreign Narcotics Kingpin Designation Act, sanctioned three Chinese nationals for their role in an international drug trafficking ring.

In of itself, the move is not unusual. But looking beyond the headlines, OFAC's press release contains some intriguing information. According to the agency, the Chinese group had laundered much of its drug proceeds via digital currency, mainly bitcoin.  Cryptocurrencies: The next chapter lies in regulation In response, OFAC included 11 bitcoin addresses allegedly tied to the Chinese nationals as personal identifiers in its Specially Designated Nationals (SDN) list.  Strictly speaking, the addresses themselves have not been sanctioned; their inclusion in SDN lists is simply desig...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot